In an opinion piece published in The Telegraph newspaper, Streeting said that weight-loss injections could be given to unemployed people to help them get back into work and help to relieve ...

AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Immunotherapeutics.